Grants paid by Fund for Ophthalmic Knowledge Inc C/O David H Abramson Md
EIN 13-4171637 · New York, NY · Form 990, Schedule I · NTEE A12
Fund for Ophthalmic Knowledge Inc C/O David H Abramson Md of New York, NY (EIN 13-4171637) reported 8 grants paid totaling $1,245,812 to 1 recipient in tax years 2018–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,245,812
8 grants
Recipients
1
distinct organizations
Tax years
2018–2024
7 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 1 | $206,960 | — |
| 2019 | 2 | $409,608 | — |
| 2020 | 1 | $157,056 | — |
| 2021 | 1 | $56,184 | — |
| 2022 | 1 | $161,184 | — |
| 2023 | 1 | $198,692 | — |
| 2024 | 1 | $56,128 | — |
Top recipients
The 1 recipients receiving the most from Fund for Ophthalmic Knowledge Inc C/O David H Abramson Md, by grants paid, out of 1 distinct recipient.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center 13-1624182 | A | New York, NY | 8 | $1,245,812 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 8 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Memorial Sloan Kettering Cancer Center New York, NY | A | $56,128 | paid | SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. | 202543109349303024 |
| 2023 | Memorial Sloan Kettering Cancer Center New York, NY | A | $198,692 | paid | SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. | 202421379349300537 |
| 2022 | Memorial Sloan Kettering Cancer Center New York, NY | A | $161,184 | paid | SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. | 202301309349302280 |
| 2021 | Memorial Sloan Kettering Cancer Center New York, NY | A | $56,184 | paid | SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. | 202211369349304031 |
| 2020 | Memorial Sloan Kettering Cancer Center New York, NY | A | $157,056 | paid | SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. | 202133089349301718 |
| 2019 | Memorial Sloan Kettering Cancer Center New York, NY | A | $204,804 | paid | SUPPORTED BASIC AND CLINICAL RESEARCH IN CANCER PERFORMED AT MSKCC AND RESULTING IN MORE THAN 15 PEER REVIEWED SCIENTIFIC PUBLICATIONS. | 202023189349302822 |
| 2019 | Memorial Sloan Kettering Cancer Center New York, NY | A | $204,804 | paid | SUPPORTED BASIC AND CLINICAL RESEARCH IN CANCER PERFORMED AT MSKCC AND RESULTING IN MORE THAN 15 PEER REVIEWED SCIENTIFIC PUBLICATIONS. | 202023189349302822 |
| 2018 | Memorial Sloan Kettering Cancer Center New York, NY | A | $206,960 + $8,835 non-cash | paid | MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC") ($215,795) -A) SUPPORT THE RESEARCH AND CLINICAL STUDIES FOR RETINOBLASTOMA ($150,000): THESE FUNDS SUPPORTED THE RESEARCH CONDUCTED AT MSK DURING THE YEAR. IT RESULTED IN 16 PUBLICATIONS IN PEER REVIEWED JOURNALS INCLUDING THE BRITISH JOURNAL OF OPHTHALMOLOGY, OPHTHALMOLOGY, AMERICAN JOURNAL OF OPHTHALMOLOGY, NEOPLASIA, PLOS1, INT J OF RETINA AND VITREOUS, JAMA OPHTHALMOLOGY, OPHTHALMIC GENETICS AND IOVS. THE TOTAL NUMBER OF AUTHORS SUPPORTED BY THESE FUNDS IN 2018 WAS 52.B) CYCLE FOR SURVIVAL ($55,000): DONATION TO THE CYCLE CHARITY-THE YEARLY FUND RAISER AT MSK TO SUPPORT RESEARCH IN RARE CANCERS.C) RESEARCH EQUIPMENT AND SUPPLIES ($10,795): COMPUTERS, STATISTICIANS, REPRINTS, PRODUCTION OF SCIENTIFIC ARTICLES AND ONGOING RESEARCH AT MSK, INCLUDING CHARGES BY LABS FOR PROCESSING SPECIMENS FOR RESEARCH. | 201912049349301056 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202543109349303024 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.0 | 202421379349300537 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202301309349302280 |
| 990 | 2021 | 2021-12-31 | not stated | 2021v4.2 | 202211369349304031 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202133089349301718 |
| 990 | 2019 | 2019-12-31 | not stated | 2019v5.1 | 202023189349302822 |
| 990 | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201912049349301056 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/134171637.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.